© Rosalind Scientific LLC 2018-2022
© Rosalind Scientific LLC, 2018-2022
New Drug Hunter content, featured events and job postings straight to your inbox. Trusted by >3,500 drug hunters worldwide, unsubscribe anytime.
<< Back to June
selective oral ATR kinase inhibitor
in Ph. I for adv. solid tumors and lymphomas
from HTS and modeling on PI3Kg structure
J. Med. Chem., Jun. 5, 2020
Bayer AG, Berlin, DE
BAY 1895344 is a potent and highly selective inhibitor of the ATR kinase, which is involved in the DNA damage response. Further disruption of the DNA damage response via ATR…
Ask your company or librarian about a Drug Hunter membership to to see all summaries and get access to even more helpful information.